Session Information
2010 Summer Meeting
Click here to go to the previous page
Controversies in Thrombosis Prevention: Update on Antiplatelet and Anticoagulation Therapies
Track:
Educational Sessions (CE)
Program Code: 111-L01
Date: Tuesday, June 8, 2010
Time: 8:00 AM to 10:00 AM EST
Location:
TCC - Ballroom D, 1st Floor
MEETING PROGRAMMING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
PRESENTER(S):
Dr. Joel Marrs, Pharm.D., BCPS (AQ Cardiology), CLS, Assistant Professor, University of Colorado Denver School of Pharmacy
Robert Page II
- Define the latest issues in antiplatelet and anticoagulation therapy.
- Identify and correct complications involving clopidogrel interactions in specified cases.
- Identify potential roles in therapy for newer antiplatelet and anticoagulant therapies.
- Recommend appropriate therapy that uses aspirin for the primary prevention of myocardial infarction (MI) in specified cases.
This session is a part of:
This session is a part of: